You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Anastrozole - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for anastrozole and what is the scope of freedom to operate?

Anastrozole is the generic ingredient in two branded drugs marketed by Accord Hlthcare, Apotex Inc, Beijing Yiling, Chartwell Molecular, Chartwell Rx, Cipla, Eugia Pharma, Fresenius Kabi Usa, Hikma, Impax Labs Inc, Kenton, Mylan, Natco Pharma Ltd, Sandoz, Sun Pharm Inds Ltd, Synthon Pharms, Teva Pharms, Watson Labs Teva, Zydus Pharms Usa Inc, and Ani Pharms, and is included in twenty NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-four drug master file entries for anastrozole. Twenty-three suppliers are listed for this compound. There is one tentative approval for this compound.

Drug Prices for anastrozole

See drug prices for anastrozole

Drug Sales Revenue Trends for anastrozole

See drug sales revenues for anastrozole

Recent Clinical Trials for anastrozole

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
ETOP IBCSG Partners FoundationPhase 2
University of MiamiPhase 2
Ottawa Hospital Research InstitutePhase 4

See all anastrozole clinical trials

Generic filers with tentative approvals for ANASTROZOLE
Applicant Application No. Strength Dosage Form
⤷  Try a Trial⤷  Try a Trial1MGTABLET;ORAL

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

Pharmacology for anastrozole
Drug ClassAromatase Inhibitor
Mechanism of ActionAromatase Inhibitors

US Patents and Regulatory Information for anastrozole

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms ARIMIDEX anastrozole TABLET;ORAL 020541-001 Dec 27, 1995 AB RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Cipla ANASTROZOLE anastrozole TABLET;ORAL 091164-001 Jun 28, 2010 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Beijing Yiling ANASTROZOLE anastrozole TABLET;ORAL 206037-001 Nov 9, 2018 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Apotex Inc ANASTROZOLE anastrozole TABLET;ORAL 200654-001 May 11, 2012 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Chartwell Rx ANASTROZOLE anastrozole TABLET;ORAL 090732-001 Jun 28, 2010 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Watson Labs Teva ANASTROZOLE anastrozole TABLET;ORAL 078984-001 Jun 28, 2010 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Fresenius Kabi Usa ANASTROZOLE anastrozole TABLET;ORAL 090088-001 Jun 28, 2010 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.